- Report
- August 2024
- 132 Pages
Global
From €2668EUR$2,990USD£2,352GBP
- Report
- December 2023
- 89 Pages
United States
From €1338EUR$1,500USD£1,180GBP
- Report
- December 2023
- 95 Pages
Europe
From €1606EUR$1,800USD£1,416GBP
- Report
- October 2023
- 133 Pages
Global
From €2231EUR$2,500USD£1,967GBP
- Report
- August 2022
- 325 Pages
Global
From €3123EUR$3,500USD£2,754GBP
- Report
- January 2022
- 385 Pages
Global
From €3346EUR$3,750USD£2,950GBP
- Report
- August 2020
- 292 Pages
Global
From €3123EUR$3,500USD£2,754GBP
- Report
- April 2020
- 233 Pages
Global
From €3123EUR$3,500USD£2,754GBP
- Report
- June 2024
- 310 Pages
Global
From €2186EUR$2,450USD£1,928GBP
- Report
- October 2023
- 280 Pages
Global
From €2186EUR$2,450USD£1,928GBP
- Report
- February 2022
- 240 Pages
Global
From €2141EUR$2,400USD£1,888GBP
From €1963EUR$2,200USD£1,731GBP
- Report
- May 2024
- 215 Pages
United States
From €2043EUR$2,290USD£1,802GBP
- Report
- March 2023
- 130 Pages
Japan
From €2222EUR$2,490USD£1,959GBP
- Report
- March 2023
- 190 Pages
Germany
From €2222EUR$2,490USD£1,959GBP
- Report
- March 2023
- 190 Pages
Switzerland
From €2222EUR$2,490USD£1,959GBP
- Report
- February 2023
- 130 Pages
France
From €2222EUR$2,490USD£1,959GBP
- Report
- February 2023
- 130 Pages
Canada
From €2222EUR$2,490USD£1,959GBP
- Report
- February 2023
- 120 Pages
Israel
From €2222EUR$2,490USD£1,959GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1776EUR$1,990USD£1,566GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more